🇺🇸 FDA
Patent

US 8258252

Sustained-release composition and process for producing the same

granted A61KA61K38/09A61K9/1647

Quick answer

US patent 8258252 (Sustained-release composition and process for producing the same) held by Takeda Pharmaceutical Company Limited expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/09, A61K9/1647, A61P, A61P13/08